Safety and Effectiveness of Capivasertib with Fulvestrant in Patients with Advanced Breast Cancer and Diabetes – a Multi-country Observational Study using Secondary Real-World Data (CAPIseid) First published 17/12/2025 Last updated 17/12/2025 EU PAS number:EUPAS1000000805 Study Planned